Insigneo Advisory Services’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
Insigneo Advisory Services's OCUL Position: Q3 2026 in Review
Insigneo Advisory Services held its Ocular Therapeutix (OCUL) position steady in Q3 2026 at 10,000 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #813.
Insigneo Advisory Services first reported a position in OCUL in Q1 2026 and has held it in 3 quarters since. The position peaked at $98.2K in Q2 2026. 258 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Insigneo Advisory Services held 10,000 shares of Ocular Therapeutix worth $76.7K as of Q3 2026.
- Insigneo Advisory Services left its Ocular Therapeutix share count unchanged in Q3 2026.
- Ocular Therapeutix made up ﹤0.01% of Insigneo Advisory Services's portfolio in Q3 2026, its #813 holding.
- Insigneo Advisory Services first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 3 quarters since.
- Insigneo Advisory Services's Ocular Therapeutix position peaked at $98.2K in Q2 2026.
- 258 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Insigneo Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.